Moreover, miR-106b-5p modulates key molecular pathways shared between cancer progression and cardiovascular dysfunction, including critical targets such as PTEN and p21/CDKN1A and the PI3K/AKT and TGF-βsignaling cascades [10,22,90,91]. Here, CDKN1A is linked to cancer.